CRISPR, Gene Editing & DNA-Repair Antibodies
CRISPR efficiency is only part of the result. Evaluate DNA-damage signaling, repair-pathway activation, and editing outcomes with antibodies targeting Cas9, RAD51, BRCA2, DNA-PK, γH2AX, ATM, ATR, and other key genome-stability proteins.
Catalog #1: bs-102335p-20ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-101876p-20ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-101819p-20ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-101500p-20ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-101523p-20ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-101343p-20ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-42427p-100ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-10856p-100ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-42066p-100ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-41498p-100ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bs-42161p-100ug
Applications: Others
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bsm-70054M
Applications: WB, IHC
Reactivity: Others
Conjugate: Unconjugated
Catalog #1: bsm-52960r
Applications: WB, FCM, IHC-P, IHC-F, IF(IHC-P), IF(ICC)
Reactivity: Others
Conjugate: Unconjugated